Cargando…
A rare case of recurrent ovarian cancer with TPM3-NTRK1 gene rearrangement: A case report
NTRK gene fusion is rare in gynecological cancer. Entrectinib is a novel targeted drug, which is a potent inhibitor of TRK A, B and C. The present case report described a case of recurrent ovarian cancer with TPM3-NTRK1 rearrangement, which was detected by next-generation sequencing (NGS) and treate...
Autores principales: | Endo, Yuta, Watanabe, Takafumi, Saito, Motonobu, Saito, Katsuharu, Suzuki, Rei, Sano, Hideki, Natori, Yutaka, Sasaki, Eisaku, Ueda, Makiko, Kamo, Norihito, Furukawa, Shigenori, Soeda, Shu, Kono, Koji, Saji, Shigehira, Fujimori, Keiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892455/ https://www.ncbi.nlm.nih.gov/pubmed/35251641 http://dx.doi.org/10.3892/mco.2022.2523 |
Ejemplares similares
-
Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab
por: Natori, Yutaka, et al.
Publicado: (2020) -
Successful management of pelvic recurrence of MSI-High endometrial cancer by total pelvic exenteration followed by administration of pembrolizumab: A case report
por: Kojima, Manabu, et al.
Publicado: (2022) -
Rare Hereditary Gynecological Cancer Syndromes
por: Watanabe, Takafumi, et al.
Publicado: (2022) -
The measurement of stiffness of uterine smooth muscle tumor by elastography
por: Furukawa, Shigenori, et al.
Publicado: (2014) -
Infantile fibrosarcoma with TPM3-NTRK1 fusion in a boy with Bloom syndrome
por: Huson, Sue M., et al.
Publicado: (2020)